Global Skin Grafting Device Market Is Estimated To Witness High Growth Owing To Opportunity In Addressing Rising Skin Defects
Skin grafting devices are essential for managing various skin defects and assist in wound healing. These devices help in transplantation of healthy skin that acts as a protective barrier against infections. Skin grafting devices come in various types such as mesh graft, split-thickness graft, full-thickness graft, and composite graft depending on the type and severity of skin defects. These devices offer accurate harvesting and placement of skin flaps.
The global Skin Grafting Device Market
is estimated to be valued at US$ 942.3 million in 2023 and is expected to
exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in
a new report published by CoherentMI.
Market Opportunity:
The rising incidence of burns, chronic wounds, and skin
reconstruction surgeries have created significant demand for skin grafting procedures.
According to the American Burn Association, over 450,000 burn injuries require
medical attention annually in the United States. Skin grafting devices are
vital in managing major burn injuries and accelerating wound healing. The
growing prevalence of skin defects due to burns or traumatic injuries opens up
opportunities for skin grafting device manufacturers to offer innovative
solutions that can effectively address unmet needs and improve clinical
outcomes. This emerging need for managing severe skin defects is expected to
propel the global skin grafting device market during the forecast period.
Porter’s Analysis:
Threat of new entrants: The global
skin grafting device market is moderately difficult to enter due to high
capital requirements and stringent regulatory approval process. Furthermore,
established brands have strong brand loyalty which poses barrier.
Bargaining power of buyers: The
bargaining power of buyers is moderate as skin grafting devices are medical
necessities. However, availability of substitutes provides some buyer power.
Bargaining power of suppliers: The
bargaining power of suppliers is moderate as there are many suppliers for raw
materials and components. However, suppliers hold relatively lower power as
they are dependent on few big buyers.
Threat of new substitutes: The
threat of new alternatives is moderate as new advanced skin substitute
technology is emerging.
Competitive rivalry: The competitive
rivalry is high as market is dominated by few key global players. Price wars
are common to gain market share.
SWOT Analysis:
Strength: Well-established
distribution channel, strong R&D on innovative skin substitutes, funding
for research from government and private bodies.
Weakness: High cost associated with
manufacturing and compliance, technical limitations of existing devices.
Opportunity: Rising incidence of
burns and skin ulcers, growing awareness about skin grafts, emerging markets of
Asian and Latin American countries.
Threats: Stringent regulatory norms,
reimbursement issues in developing nations, potential substitutes like stem
cell therapy.
Skin Grafting Device Market
Segmentation:
By Product Type
Dermal Substitutes
Acellular
Cellular Allogeneic
Cellular Autologou
By Graft Thickness
Split-Thickness
Full-Thickness
Composite Grafts
By Application
Burns
Traumatic Wounds
Surgical Wounds
Chronic Wounds
Others
By End user
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Key Takeaways:
The global Skin
Grafting Device Market Size is estimated to be valued at US$ 942.3
million in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast
period 2023 to 2030.
Key players
Key players operating in the global skin grafting device market are Avita Medical, Smith & Nephew, MiMedx Group, Organogenesis, Zimmer Biomet, Medtronic, Tissue Regenix, Integra Lifesciences, Anika Therapeutics, Nouvag, AlloSource, Merakris Therapeutics, LLC.
Explorer more information on this topic, Please visit @ https://www.ukwebwire.com/skin-grafting-device-market-size-and-share-analysis/
Comments
Post a Comment